Morimont Philippe, Habran Simon, Desaive Thomas, Blaffart Francine, Lagny Marc, Amand Theophile, Dauby Pierre, Oury Cecile, Lancellotti Patrizio, Hego Alexandre, Defraigne Jean-Olivier, Lambermont Bernard
Medical Intensive Care Unit, Department of Medicine, University Hospital of Liège, Liège, Belgium.
GIGA-Research, Critical Care Basic Sciences, University of Liège, Liège, Belgium.
Artif Organs. 2019 Aug;43(8):719-727. doi: 10.1111/aor.13431. Epub 2019 Feb 26.
Low flow extracorporeal veno-venous CO removal (ECCO R) therapy is used to remove CO while reducing ventilation intensity. However, the use of this technique is limited because efficiency of CO removal and potential beneficial effects on pulmonary hemodynamics are not precisely established. Moreover, this technique requires anticoagulation that may induce severe complications in critically ill patients. Therefore, our study aimed at determining precise efficiency of CO extraction and its effects on right ventricular (RV) afterload, and comparing regional anticoagulation with citrate to systemic heparin anticoagulation during ECCO R. This study was performed in an experimental model of severe hypercapnic acidosis performed in two groups of three pigs. In the first group (heparin group), pigs were anticoagulated with a standard protocol of unfractionated heparin while citrate was used for ECCO R device anticoagulation in the second group (citrate group). After sedation, analgesia and endotracheal intubation, pigs were connected to a volume-cycled ventilator. Severe hypercapnic acidosis was obtained by reducing tidal volume by 60%. ECCO R was started in both groups when arterial pH was lower than 7.2. Pump Assisted Lung Protection (PALP, Maquet, Rastatt, Germany) system was used to remove CO . CO extraction, arterial pH, PaCO as well as systemic and pulmonary hemodynamic were continuously followed. Mean arterial pH was normalized to 7.37 ± 1.4 at an extracorporeal blood flow of 400 mL/min, coming from 7.11 ± 1.3. RV end-systolic pressure increased by over 30% during acute hypercapnic acidosis and was normalized in parallel with CO removal. CO extraction was not significantly increased in citrate group as compared to heparin group. Mean ionized calcium and MAP were significantly lower in the citrate group than in the heparin group during ECCO R (1.03 ± 0.20 vs. 1.33 ± 0.19 and 57 ± 14 vs. 68 ± 15 mm Hg, respectively). ECCO R was highly efficient to normalize pH and PaCO and to reduce RV afterload resulting from hypercapnic acidosis. Regional anticoagulation with citrate solution was as effective as standard heparin anticoagulation but did not improve CO removal and lead to more hypocalcemia and hypotension.
低流量体外静脉 - 静脉二氧化碳清除(ECCO₂R)疗法用于清除二氧化碳,同时降低通气强度。然而,该技术的应用受到限制,因为二氧化碳清除效率以及对肺血流动力学的潜在有益作用尚未明确确立。此外,该技术需要抗凝,这可能在危重症患者中引发严重并发症。因此,我们的研究旨在确定二氧化碳提取的精确效率及其对右心室(RV)后负荷的影响,并比较ECCO₂R期间柠檬酸盐局部抗凝与全身肝素抗凝的效果。本研究在两组各三头猪的严重高碳酸血症酸中毒实验模型中进行。在第一组(肝素组)中,猪采用普通肝素的标准方案进行抗凝,而在第二组(柠檬酸盐组)中,柠檬酸盐用于ECCO₂R装置抗凝。在镇静、镇痛和气管插管后,猪连接到容量控制通气机。通过将潮气量降低60%获得严重高碳酸血症酸中毒。当动脉pH低于7.2时,两组均开始ECCO₂R。使用泵辅助肺保护(PALP,德国马奎特公司,拉施塔特)系统清除二氧化碳。持续监测二氧化碳提取、动脉pH、动脉血二氧化碳分压(PaCO₂)以及全身和肺血流动力学。在体外血流量为400 mL/min时,平均动脉pH从7.11±1.3恢复正常至7.37±1.4。在急性高碳酸血症酸中毒期间,右心室收缩末期压力增加超过30%,并随着二氧化碳清除而恢复正常。与肝素组相比,柠檬酸盐组的二氧化碳提取没有显著增加。在ECCO₂R期间,柠檬酸盐组的平均离子钙和平均动脉压显著低于肝素组(分别为1.03±0.20 vs. 1.33±0.19和57±14 vs. 68±15 mmHg)。ECCO₂R在使pH和PaCO₂恢复正常以及降低高碳酸血症酸中毒导致的右心室后负荷方面非常有效。柠檬酸盐溶液局部抗凝与标准肝素抗凝效果相同,但没有改善二氧化碳清除,且导致更多的低钙血症和低血压。